Financing
CME Group·Cash Flow Statement·16 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Change in performance bond and guaranty fund contributions | $8.8B | -$13.8B | $18B | -$21.8B | -$21.5B | -$6.9B | $110.9B | -$5.4B |
| Dividends paid | $418.5M | $418.5M | $418.8M | $2.6B | $455.3M | $455.3M | $455M | $2.7B |
| Net cash from financing activities | -$9.2B | $13.3B | — | $19.2B | $21B | $6.4B | $9.9B | $2.1B |
| Net proceeds (payments) from derivative instrument financing activities | — | $0 | $0 | $0 | $8.2M | $0 | $257.9M | $538.7M |
| Net Cash from Derivative Financing Activities | — | $0 | $0 | $0 | $8.2M | $0 | $257.9M | $538.7M |
| Cash Flows from Financing Derivatives | — | $0 | $0 | $0 | $8.2M | $0 | $257.9M | $538.7M |
| Taxes paid for net share settlement | $100K | $17.1M | $3.5M | $8.2M | $600K | $22.2M | $2.9M | $22M |
| Other, net | -$300K | -$4.4M | -$200K | -$4.4M | -$100K | -$4.3M | $0 | -$4.4M |
| Payment of Deferred Purchase Consideration | -$300K | -$4.4M | -$200K | -$4.4M | -$100K | -$4.3M | $0 | -$4.4M |
| Noncontrolling interest transactions and other | -$300K | -$4.4M | -$200K | -$4.4M | -$100K | -$4.3M | $0 | -$4.4M |
| Other financing activities | -$300K | -$4.4M | -$200K | -$4.4M | -$100K | -$4.3M | $0 | -$4.4M |
| Noncontrolling Interests Activity and Other | -$300K | -$4.4M | -$200K | -$4.4M | -$100K | -$4.3M | $0 | -$4.4M |
| Debt Borrowings, Net of Issuance Costs | $0 | $0 | $0 | $742.3M | — | — | — | $0 |
| Proceeds from issuance of debt | $0 | $0 | $0 | $742.3M | — | — | — | $0 |
| Repayments of debt | $0 | $0 | — | $750M | — | — | — | $0 |
| Proceeds from Debt Financing, Net of Issuance Costs | $0 | $0 | $0 | $742.3M | — | — | — | $0 |